DRUG CIK: 1827401

Bright Minds Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions CAD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions CAD
FY21:
−8.79
FY22:
−15.0
FY23:
−7.39
FY24:
–
FY25:
−13.9
(positive)
Change from FY21 to FY25
millions CAD
FY21:
−8.94
FY22:
−15.0
FY23:
−7.33
FY24:
–
FY25:
−14.0
(positive)
Change from FY21 to FY25
millions CAD
FY21:
−8.65
FY22:
−15.0
FY23:
−7.37
FY24:
–
FY25:
−12.2
(positive)
Change from FY21 to FY25
millions CAD
FY21:
−8.65
FY22:
−15.0
FY23:
−7.37
FY24:
−2.80
FY25:
−12.2

All amounts in millions CAD Data sources:SEC EDGARTwelve Data